3
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Role of Macrophages in Pulmonary Late-Phase Reaction in Guinea Pigs

, &
Pages 395-405 | Published online: 02 Jul 2009

References

  • Pepys J, Hutchcroft BJ. Bronchial provocation tests in the etiologic diagnosis and analysis of asthma. Am Rev Respir Dis 1975; 222: 829–859
  • Booij-Noord H, Orie N GM, De Vries K. Immediate and late bronchial obstructive reactions to inhalation of house dust and protective effects of disodium cro-moglycate and prednisolone. J Allergy Clin Immunol 1971; 48: 344–354
  • Holgate S T, Benyon R C, Howarth P H, Agius R, Hardly C, Robinson C, Durham S R, Kay A B, Church MK. Relationship between mediator release from human lung mast cells in vitro and in vivo. Int Arch Allergy Appl Immunol 1985; 77: 47–56
  • Metzer W J, Richerson H B, Worden K, Monick M, Hunninghake GW. Bronchoalveolar lavage of allergic asthmatic patients following allergen provocation. Chest 1986; 89: 477–483
  • De Monchy J GR, Kauffman H F, Venge P, Koetger G H, Jansen H M, Sluiter H J, De Vries K. Bronchoalveolar eosinophilia during allergen-iiiduced late asthmatic reactions. Am Rev Respir Dis 1985; 131: 373–376
  • Frew A J, Moqbel R, Azzawi M, Hartnell A, Barkans J, Jeffery P K, Kay A B, Scheper R J, Varley J, Church M K, Holgate T. T lymphocytes and eosinophils in allergen-induced late-phase asthmatic reactions in the guinea pigs. Am Rev Respir Dis 1990; 141: 407–413
  • Hunninghake GW. Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis. Am Rev Respir Dis 1984; 229: 569–572
  • Wewers M D, Rennard S I, Hance A J, Birterman P B, Crystal RG. Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1. J Clin Invest 1984; 74: 2208–2218
  • Bachwich P R, Lynch J P, Larrick J, Spaigler M, Kunkel SL. Tumor necrosis factor production by human sarcoid alveolar macrophages. Am J Pathol 1986; 225: 421–425
  • Merril W W, Naegel G P, Matthay R A, Reynolds HY. Alveolar macrophage-derived chemotactic factor for neutrophils: Kinetics of “in vitro” production and partial characterization. J Clin Invest 1980; 66: 473–483
  • Pennington J E, Rossing T H, Boertli L W, Lee TH. Isolation and partial characterization of a human alveolar macrophage-derived neutrophil-activating factor. I Clin Invest 1985; 75: 1230–1237
  • Sylvester I, Rankin J A, Yoshimura T, Tanaka S, Leonard EJ. Secretion of neutrophil attractant/activation protein by lipopolysaccharide-stimulated lung macrophages determined by both enzyme-linked immunosorbent assay and N-terminal sequence analysis. Am Rev Respir Dis 1990; 142: 683–688
  • Capron M, Tonnel AB. Participation of Fc epsilon RII-positive macrophages and eosinophils in asthma. Asthma: Its Pathology and Treatment, M A Kaliner, P J Barnes, C G Persson. Marcel Dekker, New York 1991; 457–476
  • Fuller R W, Morris P K, Richmond R, Sykes D, Varndell I M, Kemeny D M, Cole P J, Dollery C T, Macder-mot J. Immunoglobulin E-dependent stimulation of human alveolar macrophages: Significance in type I hypersensitivity. Clin Exp Immunol 1986; 65: 416–26
  • Samuelsson B. Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation. Science 1983; 220: 568–575
  • Arnoux B A, Duval D, Benveniste J. Releaseof platelet activating factor (PAF-acether) from alveolar macrophages by the calcium ionophore A23187 and phagocytosis. Eur J Clin Invest 1980; 70: 437–441
  • Fleisch H. Bisphosphonates: Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease. Drugs 1992; 42: 919–944
  • Schenk R, Merz W A, Muhlbauer R, Russell R GG, Fleisch H. Effect of ethane-l-hydroxy-1, 1-diphos-phonate (EHDP) and dichloromethylene diphosphonate (ChMDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats. Calcif Tissue Res J 1973; 7: 196–214
  • Van Rooijen N, Van Nieuwmegen R. Elimination of phagocytic cells in the spleen after intravenous injection of liposome-encapsulated dichloromethylene diphosphonate. Cell Tissue Res 1984; 238: 355–358
  • Thepen T, Van Rooijen N, Kraal G. Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J Exp Med 1989; 170: 499–509
  • Okada S, Inoue H, Asano M, Iijima H, Tnkishima T. Adjuvant effect of interleukin-1 on the development of late asthmatic response in guinea pigs. Int Arch Allergy Immunol 1993; 700: 164–169
  • Iijima H, Ishii M, Yamauchi K, Chao C L, Kimura K, Shimura S, Shindoh Y, Inoue H, Mue S, Takishima T. Bronchoalveolar lavage and histologic characterization of late asthmatic response in guinea pigs. Am Rev Respir Dis 1987; 136: 922–929
  • Yamada N, Ohgaki M, Muramatsu M. Repirinast inhibits antigen-induced early and late pulmonary responses and airway hyperresponsiveness in guinea pigs. Int Arch Allergy Immunol 1993; 100: 367–372
  • Hyatt R E, Zimmerman I R, Peters G M, Sullivan WJ. Direct write-out of respiratory resistance. J Appl Physiol 1970; 28: 675–678
  • Ochi K, Yoshimoto T, Yamamoto S, Taniguchi K, Miyamoto T. Arachidonate 5-lipoxygenase of guinea pig peritoneal polymorphonuclear leukocytes. J Biol Chem 1983; 258: 5754–5758
  • Dahinden C A, Clancy R M, Hugli TE. Stereospecificity of leukotriene B4 and structure-function relationships for chemotaxis of human neutrophils. J Immunol 1984; 133: 1477–1482
  • Ryman B E, Tyrrell DA. Liposomes-bags of potential. Essays Bicohem 1980; 18: 49–98
  • Dunn C J, Galinet L A, Wu H, Nugait R A, Schlachter S T, Staite N D, Aspar D G, Elliott G A, Essani N A, Rohloff N A, Smith RJ. Demonstration of novel anti-arthritic and anti-inflammatory effects of diphosphonates. J Pharmacol Exp Ther 1993; 266: 1691–1698
  • Flanagan A M, Chambers TJ. Dichloromethylene bisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated bone. Bone Mineral 1989; 6: 33–43
  • Cecchini M G, Fleisch H. Bisphosphonates in vitro specifically inhibit, among hematopoietic series, the development of the mouse mononuclear phagocyte lineage. J Bone Miner Res 1990; 5: 1019–1027
  • Stevenson P H, Stevenson JR. Cytotoxic and migration inhibitory effects of bisphosphonates on macrophages. Calcif Tiss Int 1986; 38: 227–233
  • Mönkkönen J, Urtti A, Paronen P, Elo H A, Ylitalo P. The uptake of clodronate (dichloromethylene bisphosphonate) by macrophages in vivo and in vitro. Drug Metab Dispos 1989; 17: 690–693
  • Markkula R, Repo H, Leirisalo M, Blomqvist C, Elomaa I. Effect of dichloromethylene diphosphonate (Cl2MDP) on immune function in breast cancer patients with bone metastasis. Cancer Immunol Immunother 1983; 15: 159–161
  • Metzger W J, Richerson H B, Worden K, Monick M, Hunninghake GW. Bronchoalveolar lavage of allergic asthmatic patients following allergen provocation. Chest 1986; 89: 477–483
  • Delehunt J C, Perruchoud A P, Yerger L, Marchette B, Stevenson J S, Abraham WM. The role of slow reacting substance of anaphylaxis in the late bronchial response after allergen challenge in allergic sheep. Am Rev Respir Dis 1984; 130: 748–754
  • Nagy L, Lee T H, Kay AB. Neutrophil chemotactic activity in antigen-induced late asthmatic reactions. N Engl J Med 1982; 306: 497–501
  • Murphy K R, Wilson M C, Irvin C G, Glezen L S, Marsh W R, Haslett C, Henson P M, Larsen GL. The requirement for polymorphonuclear leukocytes in the late asthmatic response and heightened airways reactivity in an animal model. Am Rev Respir Dis 1986; 134: 62–68
  • Lemanske R F, G u thman DA, Oertel H, Barr L, Kaliner M. The biologic activity of mast cell granules. VI. The effect of viblastine-induced neutropaenia on rat cutaneous late phase reactions. J Immunol 1983; 130: 2837–2842
  • Lemanske R F, Guthman D A, Kaliner M. The biologic activity of mast cell granules. VII. The effect of anti-neutrophil antibody-induced neutropaenia on rat cutaneous late phase reactions. J Immunol 1983; 131: 929–933
  • Hutson P A, Holgate S T, Church MK. The effect of cromolyn sodium and albuterol on early and late phase bronchoconstriction and airway leukocyte infiltration after allergen challenge of nonanesthetized guinea pigs. Am Rev Respir Dis 1988; 138: 1157–1163
  • Hutson P A, Varley J G, Sanjar S, Kings M, Holgate S T, Church MK. Evidence that neutrophils do not participate in the late-phase response provoked by ovalbumin inhalation in conscious, sensitized guinea pigs. Am Rev Respir Dis 1990; 141: 535–539
  • Luscinskas F W, Cybulsky M I, Kiely J-M, Peckins C S, Davis V M, Gimbrone MA. Cytokine-activated human endothelial monolayers support enhanced neutrophil transmigration via a mechanism involving both endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule-1. J Immunol 1991; 146: 1617–1625
  • Swerlick R A, Lee K H, Li I, Sepp N T, Caughman S W, Lawley TJ. Regulation of vascular cell adhesion molecule 1 on human dermal microvascular endothelial cells. J Immunol 1992; 149: 698–705
  • Schröder J M, Mrowietz U, Morita E, Christophers E. Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. J Immunol 1987; 139: 3474–3483
  • Yoshimura T, Matsushima K, Oppenheim J J, Leonard EJ. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL-1). J Immunol 1987; 139: 788–793
  • Thelen M, Peveri P, Kernen P, Von Tscharner V, Walz A, Baggiolini M. Mechanism of neutrophil activation by NAF, a novel monocyte-derived peptide agonist. FASEB J 1988; 2: 2702–2706
  • Peveri P, Walz A, Dewald B, Baggiolini M. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med 1988; 167: 1547–1559
  • Melewicz F M, Zeiger R S, Mellon M H, O'Connor R D, Spiegelberg HL. Increased IgE-dependent cytotoxicity by blood mononuclear cells of allergic patients. Clin Exp Immunol 1981; 43: 526–533
  • Joseph M, Tonnel A-B, Torpier G, Capron A, Arnoux B, Benveniste J. Involvement of immunoglobulin E in the secretory processes of alveolar macrophages from asthmatic patients. J Clin Invest 1983; 77: 221–230
  • Walsh G M, Mermod J-J, Hartnell A, Kay A B, Ward-law AJ. Human eosinophil, but not neutrophil, adherence to IL-1-stimulated human umbilical vascular endothelial cells is α4β1 (very late antigen-1) dependent. J Immunol 1991; 146: 3419–3423
  • Weller P F, Rand T H, Goelz S E, Chi-Rosso G, Lobb RR. Human eosinophil adherence to vascular endothelium mediated by binding to vascular cell adhesion molecule 1 and endothelial leukocyte molecule 1. Proc Natl Acad Sci USA 1991; 88: 7430–7433
  • Schleimer R P, Sterbinsky S A, Kaiser J, Bickel C A, Klunk D A, Tomioka K, Newman W, Luscinskas F W, Gimbrone M A, McIntyre B W, Bochner BS. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. J Immunol 1992; 148: 1086–1092
  • Mosmann T R, Coffman RL. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145–173
  • Plaut M, Pierce J H, Watson C J, Hanley-Hyde J, Nordan R P, Paul WE. Mast cell lines produce lymphokines in response to cross-linkage of Fcri or to calcium ionophores. Nature 1989; 339: 64–67

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.